Karton Y - Search Results

1

Functionalized congener approach to muscarinic antagonists: analogues of pirenzepine.

Karton Y, Bradbury BJ, Baumgold J, Paek R, Jacobson KA. Karton Y, et al. J Med Chem. 1991 Jul;34(7):2133-45. doi: 10.1021/jm00111a032. J Med Chem. 1991. PMID: 2066986 Free PMC article.

2

Molecular probes for muscarinic receptors: derivatives of the M1-antagonist telenzepine.

Karton Y, Baumgold J, Handen JS, Jacobson KA. Karton Y, et al. Bioconjug Chem. 1992 May-Jun;3(3):234-40. doi: 10.1021/bc00015a006. Bioconjug Chem. 1992. PMID: 1520727 Free PMC article.

3

Structure-activity relationships of 8-styrylxanthines as A2-selective adenosine antagonists.

Jacobson KA, Gallo-Rodriguez C, Melman N, Fischer B, Maillard M, van Bergen A, van Galen PJ, Karton Y. Jacobson KA, et al. Among authors: karton y. J Med Chem. 1993 May 14;36(10):1333-42. doi: 10.1021/jm00062a005. J Med Chem. 1993. PMID: 8496902 Free PMC article.

4

Synthesis and biological activities of flavonoid derivatives as A3 adenosine receptor antagonists.

Karton Y, Jiang JL, Ji XD, Melman N, Olah ME, Stiles GL, Jacobson KA. Karton Y, et al. J Med Chem. 1996 Jun 7;39(12):2293-301. doi: 10.1021/jm950923i. J Med Chem. 1996. PMID: 8691424 Free PMC article.

5

High affinity acylating antagonists for muscarinic receptors.

Baumgold J, Karton Y, Malka N, Jacobson KA. Baumgold J, et al. Among authors: karton y. Life Sci. 1992;51(5):345-51. doi: 10.1016/0024-3205(92)90586-e. Life Sci. 1992. PMID: 1625525 Free PMC article.

6

Acyl-Hydrazide Derivatives of a Xanthine Carboxylic Congener (XCC) as Selective Antagonists at Human A_2B Adenosine Receptors.

Kim YC, Karton Y, Ji XD, Melman N, Linden J, Jacobson KA. Kim YC, et al. Among authors: karton y. Drug Dev Res. 1999 Aug;47(4):178-188. doi: 10.1002/(sici)1098-2299(199908)47:4<178::aid-ddr4>3.0.co;2-l. Drug Dev Res. 1999. PMID: 35790094 Free PMC article.

7

Amyloid precursor protein secretion via muscarinic receptors: reduced desensitization using the M1-selective agonist AF102B.

Haring R, Gurwitz D, Barg J, Pinkas-Kramarski R, Heldman E, Pittel Z, Wengier A, Meshulam H, Marciano D, Karton Y, et al. Haring R, et al. Among authors: karton y. Biochem Biophys Res Commun. 1994 Aug 30;203(1):652-8. doi: 10.1006/bbrc.1994.2232. Biochem Biophys Res Commun. 1994. PMID: 8074717

8

Novel m1 muscarinic agonists in treatment and delaying the progression of Alzheimer's disease: an unifying hypothesis.

Fisher A, Brandeis R, Haring R, Eshhar N, Heldman E, Karton Y, Eisenberg O, Meshulam H, Marciano D, Bar-Ner N, Pittel Z. Fisher A, et al. Among authors: karton y. J Physiol Paris. 1998 Oct-Dec;92(5-6):337-40. doi: 10.1016/S0928-4257(99)80001-1. J Physiol Paris. 1998. PMID: 9789833 Review.

9

M1 agonists for the treatment of Alzheimer's disease. Novel properties and clinical update.

Fisher A, Heldman E, Gurwitz D, Haring R, Karton Y, Meshulam H, Pittel Z, Marciano D, Brandeis R, Sadot E, Barg Y, Pinkas-Kramarski R, Vogel Z, Ginzburg I, Treves TA, Verchovsky R, Klimowsky S, Korczyn AD. Fisher A, et al. Among authors: karton y. Ann N Y Acad Sci. 1996 Jan 17;777:189-96. doi: 10.1111/j.1749-6632.1996.tb34418.x. Ann N Y Acad Sci. 1996. PMID: 8624083 Review.

10

NGF-dependent neurotrophic-like effects of AF102B, an M1 muscarinic agonist, in PC12M1 cells.

Gurwitz D, Haring R, Pinkas-Kramarski R, Stein R, Heldman E, Karton Y, Fisher A. Gurwitz D, et al. Among authors: karton y. Neuroreport. 1995 Feb 15;6(3):485-8. doi: 10.1097/00001756-199502000-00020. Neuroreport. 1995. PMID: 7766849

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16 results

Search Page

Filters